Vanda Pharmaceuticals Inc (VNDA)
Healthcare
Biotechnology
5.20 $
+2.5%
vs. previous close
Closing price · As of: 3. Aug 2026
Vanda Pharmaceuticals Inc (VNDA) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Operating Cash Flow" came in at -50 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -13 | -2.1 | -3.7 | 7.6 | -6.9 | -15 | -1.8 | -33 | -15 | -32 | -29 | -50 | -127 | |
| 0.6 | 0.6 | 1.2 | 2.2 | 2.0 | 2.0 | 2.0 | 2.0 | -2.8 | 2.1 | 5.9 | 3.5 | 8.7 | |
| 3.2 | 3.2 | 3.3 | 3.6 | 3.0 | 3.0 | 2.9 | 3.0 | 2.1 | 2.1 | 2.3 | 2.6 | 9.1 | |
| 5.4 | – | – | – | – | – | – | – | – | – | – | – | – | |
| -19 | -6.8 | 2.8 | 7.0 | -4.6 | -9.6 | 0.7 | -1.9 | 15 | -8.1 | 3.0 | -7.9 | 2.3 | |
| 0.1 | 0.0 | 0.3 | 0.0 | 0.1 | 0.2 | 0.2 | 0.4 | 0.3 | 0.2 | 0.1 | 0.2 | 0.8 | |
| -191 | 35 | -44 | -18 | -15 | 12 | 4.0 | 44 | -15 | 21 | 45 | 20 | 71 | |
| – | – | – | – | – | – | – | -0.4 | -0.4 | -0.5 | -0.6 | -0.8 | -2.4 | |
| – | 0.0 | 0.0 | 0.0 | 0.0 | – | -0.2 | -1.3 | -0.4 | -0.5 | -0.6 | -0.8 | -2.4 | |
| -204 | 33 | -47 | -11 | -22 | -2.5 | 1.8 | 9.5 | -31 | -11 | 15 | -31 | -58 | |
| -13 | -2.1 | -4.0 | 7.6 | -7.0 | -15 | -2.0 | -34 | -16 | -32 | -30 | -50 | -127 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.